MRK Factor-Based Stock Analysis - Peter Lynch July 09, 2025 — 09:03 am EDT Written by John Reese for Validea -> Below is Validea's guru fundamental report for MERCK & CO INC (MRK).

Merck & Co., Inc. (NYSE:MRK) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. The company has a strong lineup of products in development and brings in solid revenue and ...

In the closing of the recent trading day, Merck (MRK) stood at $79.96, denoting a -1.91% move from the preceding trading day.

Merck & Company, Inc. (NYSE:MRK) is one of the high-margin pharma stocks to buy now. Jefferies has raised its price target on Merck & Co.

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of ...

Merck & Co., Inc. (NYSE: MRK) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. A close-up of a person’s hand holding a bottle of pharmaceuticals.

Review the current Merck & Co Inc (MRK:XNYS) dividend yield and history to decide if MRK is the best investment for you.

Review which funds and institutions currently hold Merck & Co Inc (MRK:XNYS) stock for ownership information.

Merck & Co., Inc. (MRK) dividend safety metrics, payout ratio calculation and chart.

Merck & Co., Inc. (MRK) dividend yield: annual payout, 4 year average yield, yield chart and 10 year yield history.